DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Oramorph SR (Morphine Sulfate) - Summary

 
 



ORAMORPH SR SUMMARY

ORAMORPH® SR
(MORPHINE SULFATE)
Sustained Release Tablets
15 mg, 30 mg, 60 mg, 100 mg

Each tablet for oral administration contains morphine sulfate.....15 mg, 30 mg, 60 mg, or 100 mg in a tablet that provides for sustained release of the medication.

ORAMORPH SR is indicated for the relief of pain in patients who require opioid analgesics for more than a few days.


See all Oramorph SR indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Oramorph SR (Morphine)

High-Risk Plaque Predicts ACS in ER Patients With Chest Pain
Source: theheart.org | Medscape Cardiology Headlines [2014.07.18]
Among patients with acute chest pain but a negative initial assessment in the ER, a coronary CT scan that detects plaque with certain features such as napkin-ring sign may identify imminent MI.
Heartwire

Exercises With or Without Abdominal Bracing in Back Pain
Source: Medscape Orthopaedics Headlines [2014.07.17]
Which type of exercise is more important in patients with recurrent low back pain -- and how does abdominal bracing influence the exercise effect?
Spine

Could 'Phone Care' Ring in New Approach to Pain Relief?
Source: MedicineNet Chronic Pain Specialty [2014.07.16]
Title: Could 'Phone Care' Ring in New Approach to Pain Relief?
Category: Health News
Created: 7/15/2014 4:35:00 PM
Last Editorial Review: 7/16/2014 12:00:00 AM

Weather May Not Affect Low Back Pain
Source: Medscape Rheumatology Headlines [2014.07.15]
Weather factors such as temperature, relative humidity, air pressure, and precipitation did not increase the risk for a low back pain episode; higher wind and wind gust speed had a minimal effect.
Medscape Medical News

Telecare intervention improves chronic pain
Source: Pain / Anesthetics News From Medical News Today [2014.07.15]
A telephone-delivered intervention, which included automated symptom monitoring, produced clinically meaningful improvements in chronic musculoskeletal pain compared to usual care, according to a...

more news >>

Published Studies Related to Oramorph SR (Morphine)

Periarticular infiltration of 0.25% bupivacaine on top of femoral nerve block and intrathecal morphine improves quality of pain control after total knee arthroplasty: a randomized double-blind placebo controlled clinical trial. [2012]
CONCLUSION: Adding periarticular infiltration to femoral block and intrathecal

Analgesic tolerance without demonstrable opioid-induced hyperalgesia: a double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain. [2012]
Although often successful in acute settings, long-term use of opioid pain medications may be accompanied by waning levels of analgesic response not readily attributable to advancing underlying disease, necessitating dose escalation to attain pain relief... Improvements in pain and functional ability were observed.

Tolerability and efficacy of two synergistic ratios of oral morphine and oxycodone combinations versus morphine in patients with chronic noncancer pain. [2012]
SETTING: Clinical study centers in Australia... CONCLUSION: A 3:2 or 1:2 fixed ratio combination of morphine and oxycodone (MOX)

Long-acting morphine following hip or knee replacement: a randomized, double-blind and placebo-controlled trial. [2012]
routine postoperative regimen for total hip or knee replacement surgery... CONCLUSIONS: Thirty milligrams twice per day of long-acting morphine from days 1

The effect of intravenous morphine on the level of spinal anesthesia with lidocaine. [2012]
CONCLUSION: Although some studies had proved the efficacy of systemic use of

more studies >>

Clinical Trials Related to Oramorph SR (Morphine)

Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction [Completed]
This study involves approximately 200 patients designed to evaluate the efficacy and safety of intranasal (IN) morphine 7. 5 mg and 15 mg, intravenous morphine (IV) 7. 5 mg, immediate release oral (PO) morphine 60 mg or placebo in patients with acute postsurgical pain following third molar extraction.

Intrathecal Morphine in Knee Arthroplasty [Completed]
This study is designed to explore the efficacy lower doses of intra-spinal morphine for pain relief and side effect profiles of same in the setting of Total Knee Replacement. We hypothesized that a dose greater than that used in Total Hip Replacement was needed and wished to find a dose which was effective but had a low side effect profile.

Efficacy and Safety of Intranasal Morphine for Pain After Bunion Surgery [Completed]
Study designed to evaluate the efficacy and safety of Intranasal (IN) Morphine Nasal Spray (MNS075) 3. 75 mg, 7. 5 mg, 15 mg, and 30 mg, intravenous (IV) morphine 7. 5 mg, or IN placebo in patients with moderate to severe post-surgical pain following orthopedic surgery. After initial dosing, up to six (6) doses of IN MNS075 7. 5 mg or 15 mg for up to twenty-four (24) hours will be evaluated. The rescue dose remained the same for each.

A Study of Kadian NT in Subjects With Pain Due to Osteoarthritis of the Hip or Knee [Completed]
The purpose of this study is to evaluate the efficacy of Kadian NT compared with placebo for treating moderate to severe chronic pain over a 12 week period.

INFUSE Morphine Study [Completed]
Double-blind study comparing the pharmacokinetics, safety and tolerability of morphine administered subcutaneously (SC) with and without human recombinant hyaluronidase (HYLENEX) and intravenously conducted in patients in a hospice care setting or through a palliative care medicine setting. In this within-patient controlled study, each eligible study patient receives a single injection by each of the three methods of morphine administration, sequentially on three consecutive days, according to the order specified by a randomization schedule.

Each of the three injections consists of 5 mg of morphine (1. 0 mL of 5 mg/mL solution). The HYLENEX injection will be 1 mL of 150 units. Although the IV administration will not be blinded, the two SC injections will be double-blinded, using the same volume of normal saline (0. 9% sodium chloride) placebo (1. 0 mL) as HYLENEX.

more trials >>

Reports of Suspected Oramorph SR (Morphine) Side Effects

Abdominal Pain (26)Cardio-Respiratory Arrest (26)Completed Suicide (6)Respiratory Depression (5)Depression (5)Multiple Drug Overdose (5)Renal Failure Acute (5)Intentional Drug Misuse (4)Lethargy (4)Respiratory Arrest (4)more >>


Page last updated: 2014-07-18

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014